RECENT NEWS
Market Intelligence Center  May 21  Comment 
Auxillium Pharmaceuticals (NASDAQ: AUXL) closed Monday's trading session at $15.10. In the past year, the stock has hit a 52-week low of $13.87 and 52-week high of $29.37. Auxillium Pharmaceuticals (AUXL) stock has been showing support around...
The Hindu Business Line  May 17  Comment 
Pharma major Dr Reddy’s Laboratories Ltd said the new pricing policy might impact 3-4 per cent of its finished dosage sales in the domestic market. The Department of Pharmaceuticals had...
The Economic Times  May 17  Comment 
Gains in technology, FMCG and realty were offset by losses in banks, pharmaceuticals and capital goods sectors.
The Hindu Business Line  May 16  Comment 
Orchid Chemicals & Pharmaceuticals has posted a loss of Rs 132.27 crore for the fourth quarter of 2012-13, compared to a net profit of Rs 20.55 crore during the previous corresponding quarter....
guardian.co.uk  May 15  Comment 
Hikma Pharmaceuticals moves to avoid 'unintended purposes' for drugs amid growing European boycott on sale to the US A drug manufacturer based in Britain has vowed to add new restrictions to sales of its products in the US after it was revealed...
Market Intelligence Center  May 15  Comment 
Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) closed Tuesday's trading session at $59.00. In the past year, the stock has hit a 52-week low of $40.38 and 52-week high of $60.79. Jazz Pharmaceuticals (JAZZ) stock has been showing support around $57.85...
Market Intelligence Center  May 15  Comment 
Auxillium Pharmaceuticals (NASDAQ: AUXL) closed Tuesday's trading session at $15.41. In the past year, the stock has hit a 52-week low of $13.87 and 52-week high of $29.37. Auxillium Pharmaceuticals (AUXL) stock has been showing support around...
FierceBiotech  May 15  Comment 
Just a few weeks after bidding farewell to its longtime CEO, Cambridge, MA-based Tokai Pharmaceuticals has rounded up $35.5 million in Series E cash to push into an expanded mid-stage study of its triple-threat treatment for prostate cancer.
The Hindu Business Line  May 15  Comment 
Shares of Elder Pharmaceuticals Ltd (EPL) bounced back with a vengeance, gaining 10 per cent or Rs 24.70 to Rs 271.75 on the BSE this morning. In a complete about-turn in investor sentim...
The Economic Times  May 15  Comment 
Sun Pharmaceuticals Ltd is a 'buy' call with a target of Rs 993 and a stop loss of Rs 948.




 

This is a list of sub-industries in the pharmaceuticals industry, and a list of their member companies



Drug Delivery

Drug Manufacturers - Major

Drug Manufacturers - Other

Drug Related Products

Biotechnology

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki